Keywords: EMEA, Adversse reaction reports, Ombudsman, Roche, Accutane, FDA, GMP

European Medicines Agency agrees to release adverse reaction reports on Roche’s acne drug Accutane; with FDA, seeks company candidates for GMP program

Article | 12 August 2010

Print This

Agreeing to open up its drug safety files for the first time, the European Medicines Agency (EMEA) has said that ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in